Therapeutic angiogenesis by the controlled of basic fibroblast growth factor for ischemic limb and heart injury: Toward safety and minimal invasiveness

Journal of Artificial Organs

Volumn 7, Issue 2, 2004, Pages 58-61

  Nakajima, Hiroyuki ^a   Sakakibara, Yutaka ^a   Tambara, Keiichi ^a   Iwakura, Atsushi ^a   Doi, Kazuhiko ^a   Marui, Akira ^a   Ueyama, Koji ^a   Ikeda, Tadashi ^a   Tabata, Yasuhiko ^b   Komeda, Masashi ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Basic fibroblast growth factor; Controlled release; Minimal invasiveness

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; GELATIN; MICROSPHERE; THALLIUM 201;

ACUTE HEART INFARCTION; ANGIOGENESIS; ANIMAL MODEL; ANIMAL TISSUE; CARDIOVASCULAR DISEASE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; GASTROEPIPLOIC ARTERY; HEART INJURY; HISTOLOGY; HYDROGEL; ISCHEMIC HEART DISEASE; LASER DOPPLER FLOWMETRY; LIMB ISCHEMIA; NONHUMAN; OMENTUM; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TISSUE BLOOD FLOW;

ANGIOGRAPHY; ANIMALS; ARTERIAL OCCLUSIVE DISEASES; COLLATERAL CIRCULATION; DELAYED-ACTION PREPARATIONS; DISEASE MODELS, ANIMAL; EXTREMITIES; FIBROBLAST GROWTH FACTOR 2; HEART INJURIES; MYOCARDIAL ISCHEMIA; NEOVASCULARIZATION, PHYSIOLOGIC; RABBITS; RATS; RATS, INBRED LEW; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, DOPPLER;

EID: 4143144093     PISSN: 14347229     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (14)

1. Tabata Y, Hijikata S, Ikada Y. Enhanced vascularization and tissue granulation by basic fibroblast growth factor impregnated in gelatin hydrogels. J Controlled Release 1994;31:189-199
2. Tabata Y, Hijikata S, Muniruzzaman M, Ikada Y. Neovascularization effect of biodegradable gelatin microspheres incorporating basic fibroblast growth factor. J Biomater Sci Polym Ed 1999;10:79-94
3. Fujita M, Tambara K. Recent insights into human coronary collateral development. Heart 2004;90:246-250
4. Horvath KA, Doukas J, Lu CY, Belkind N, Greene R, Pierce GF, Fullerton DA. Myocardial functional recovery after fibroblast growth factor 2 gene therapy as assessed by echocardiography and magnetic resonance imaging. Ann Thorac Surg 2002;74:481-486; discussion 487
5. Lazarous DF, Shou M, Scheinowitz M, Hodge E, Thirumurti V, Kitsiou AN, Stiber JA, Lobo AD, Hunsberger S, Guetta E, Epstein SE, Unger EF. Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury. Circulation 1996;94:1074-1082
6. Lopez JJ, Edelman ER, Stamler A, Hibberd MG, Prasad P, Caputo RP, Carrozza JP, Douglas PS, Sellke FW, Simons M. Basic fibroblast growth factor in a porcine model of chronic myocardial ischemia: a comparison of angiographic, echocardiographic and coronary flow parameters. J Pharmacol Exp Ther 1997;282:385-390
7. Iwakura A, Fujita M, Kataoka K, Tambara K, Sakakibara Y, Komeda M, Tabata Y. Intramyocardial sustained delivery of basic fibroblast growth factor improves angiogenesis and ventricular function in a rat infarct model. Heart Vessels 2003;18:93-99
8. Tabata Y, Nagano A, Muniruzzaman M, Ikada Y. In vitro sorption and desorption of basic fibroblast growth factor from biodegradable hydrogels. Biomaterials 1998;19:1781-1789
9. Doi K, Tabata Y, Marui A, Nishimura K, Komeda M. A novel method to enhance angiogenesis against critical limb ischemia with use of gelatin hydrogels incorporating basic fibroblast growth factor. Tissue Eng 2003;1251
10. Ueyama K, Gao B, Tabata Y, Ozeki M, Doi K, Nishimura K, Suma H, Komeda M. Development of biologic coronary artery bypass grafting in a rabbit model: Revival of a classic concept with modern biotechnology. J Thorac Cardiovasc Surg (in press)
11. Sakakibara Y, Tambara K, Sakaguchi G, Lu F, Yamamoto M, Nishimura K, Tabata Y, Komeda M. Toward surgical angiogenesis using slow-released basic fibroblast growth factor. Eur J Cardiothorac Surg 2003;24:105-111; discussion 112
12. Tambara K, Sakakibara Y, Sakaguchi G, Tabata Y, Komeda M. Administration of control-released basic fibroblast growth factor. Is it a more effective angiogenic therapy than bone marrow cell transplantation for severely ischemic hearts? Int Congr Ser 2004; 1262:356-359
13. Sakakibara Y, Nishimura K, Tambara K, Yamamoto M, Lu F, Tabata Y, Komeda M. Prevascularization with gelatin microspheres containing basic fibroblast growth factor enhances the benefits of cardiomyocyte transplantation. J Thorac Cardiovasc Surg 2002;124:50-56
14. Doi K, Tabata Y, Marui A, Nishimura K, Komeda M. Hepatocyte growth factor (HGF) or basic fibroblast growth factor (bFGF) prevents progression of monocrotaline (MCT) induced pulmonary hypertension in rats. ASCVS 2003